InsidersTradesSigma
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
Explore the full record of transactions filed by Thomas John Charles. Officer active across 1 company, notably Krystal Biotech, Inc.. Cumulatively, 2 reports have been recorded. Split: 0 buy · 1 sell. Regulator: SEC (Form 4). All data is openly available.
2 of 2 declarations